José Ignacio
García Doval
![Foto de José Ignacio](/img/nophoto.png)
![Foto de Harvard Medical School](/img/noimage_org.png)
Harvard Medical School
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Harvard Medical School (5)
2018
-
Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland
British Journal of Dermatology, Vol. 179, Núm. 4, pp. 863-871
-
Essentials for a successful registry: valid data, the right questions and timely execution
British Journal of Dermatology
2017
-
Factors associated with receiving biologics or classic systemic therapy for moderate-to-severe psoriasis: Evidence from the psonet registries
Acta Dermato-Venereologica
-
Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries
Journal of the American Academy of Dermatology, Vol. 76, Núm. 2, pp. 299-308.e16